Targeted dexamethasone nano-prodrug for corneal neovascularization management

Targeted dexamethasone nano-prodrug for corneal neovascularization management

Background: To overcome the drawbacks of traditional therapy for corneal neovascularization (CNV), we evaluated the efficacy of polyethylene glycol (PEG)-conjugated Ala-Pro-Arg-Pro-Gly (APRPG) peptide modified dexamethasone (Dex), a novel nano-prodrug (Dex-PEG-APRPG, DPA). Methods: Characterization...

Full description

Bibliographic Details
Main Authors:	Qichuan Yin, Haijie Han, Kexin Shi, Jiayue Zhou, Sifan Zheng, Ke Yao, Xingchao Shentu
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Biomedical Journal
Subjects:	Corneal neovascularization Dexamethasone Nano-prodrug Angiogenic vessel-homing peptide Targeted drug delivery
Online Access:	http://www.sciencedirect.com/science/article/pii/S231941702300029X

Similar Items

Therapeutic approaches for corneal neovascularization
by: Sepehr Feizi, et al.
Published: (2017-12-01)

Corneal neovascularization: a modern view of molecular mechanisms and methods of therapy
by: G. S. Arzhimatova, et al.
Published: (2023-07-01)

Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats
by: Li Z, et al.
Published: (2016-11-01)

Ocular Wnt/β-Catenin Pathway Inhibitor XAV939-Loaded Liposomes for Treating Alkali-Burned Corneal Wound and Neovascularization
by: Yueyang Zhong, et al.
Published: (2021-10-01)

Use of Bevacizumab in the Treatment of Corneal Neovascularization
by: Tuba Çelik, et al.
Published: (2015-01-01)

A Multifunctional Nanodrug Co-Delivering VEGF-siRNA and Dexamethasone for Synergistic Therapy in Ocular Neovascular Diseases
by: Ma X, et al.
Published: (2024-11-01)

Comparison of the Therapeutic Efficacies of Topical Rivoceranib and Topical Bevacizumab in a Murine Model of Corneal Neovascularization
by: Hyeon Jeong Yoon, et al.
Published: (2019-11-01)

Impaired Autophagy Causes Severe Corneal Neovascularization
by: Kun Yi, et al.
Published: (2022-12-01)

The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model
by: Glauco Reggiani Mello, et al.
Published: (2011-01-01)

Ferrostatin‐1‐loaded liposome for treatment of corneal alkali burn via targeting ferroptosis
by: Kai Wang, et al.
Published: (2022-05-01)

Management of corneal neovascularization: Current and emerging therapeutic approaches
by: Duoduo Wu, et al.
Published: (2024-04-01)

Triamcinolone Acetonide as an Adjunct to Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model
by: Hadi Z Mehrjardi, et al.
Published: (2014-01-01)

Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
by: Anna Krystyna Britton, et al.
Published: (2020-12-01)

Studying the Effect of Dexamethasone and Water Extract Apricot on Experimental Chemical Corneal Ulcer in Rabbit
by: Abdalbari Abbas Alfaris
Published: (2019-07-01)

Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats
by: Mohammad Nasser Hashemian, et al.
Published: (2017-01-01)

Results of combined antiangiogenic activity on corneal neovascularization. Experimental and morphological study
by: V. R. Mamikpnyan, et al.
Published: (2014-09-01)

Shark Cartilage-Derived Anti-Angiogenic Peptide Inhibits Corneal Neovascularization
by: Yunxian Li, et al.
Published: (2024-07-01)

Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
by: He Jin, et al.
Published: (2022-11-01)

Subconjunctival conbercept for the treatment of corneal neovascularization
by: Cun Sun, et al.
Published: (2023-06-01)

Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study
by: Romina Mayra Lasagni Vitar, et al.
Published: (2021-10-01)

Ocular prodrugs: Attributes and challenges
by: Jagpreet kour, et al.
Published: (2021-03-01)

Combination therapy to overcome ferroptosis resistance by biomimetic self-assembly nano-prodrug
by: Yong Huang, et al.
Published: (2023-09-01)

Clickable corneal neovascularization therapy with ROS-responsive polydopamine silica nanoparticles loaded with fenofibrate
by: Kai Fan, et al.
Published: (2023-11-01)

Risk of Induction of Corneal Neovascularization with Topical Erythropoietin: An Animal Safety Study
by: Sepehr Feizi, et al.
Published: (2023-07-01)

Inhibition of Neovascularization and Inflammation in a Mouse Model of Corneal Alkali Burns Using Cationic Liposomal Tacrolimus
by: Xueqi Lin, et al.
Published: (2021-12-01)

Comparison of the inhibitory effect of different doses of subconjunctival bevacizumab application in an experimental model of corneal neovascularization
by: Burak Ulas, et al.
Published: (2018-07-01)

Progress in Research on the Role of FGF in the Formation and Treatment of Corneal Neovascularization
by: Mengji Chen, et al.
Published: (2020-02-01)

Inhibition of corneal neovascularization by topical application of nintedanib in rabbit models
by: Juan Chen, et al.
Published: (2021-11-01)

Simultaneous Single Dexamethasone Implant and Ranibizumab Injection in a Case with Active Serpiginous Choroiditis and Choroidal Neovascular Membrane
by: Ali Osman Saatci, et al.
Published: (2015-12-01)

Effect of Different Treatment Regimen with Dexamethasone and Acetylcysteine on Corneal Wound Healing in Rabbits
by: Ali Asghar Sarchahi, et al.
Published: (2011-09-01)

Effect of trapping vascular endothelial growth factor-A in a murine model of dry eye with inflammatory neovascularization
by: Jin Woo Kwon, et al.
Published: (2016-11-01)

Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization
by: Zachary Barry, et al.
Published: (2020-07-01)

Esterase‐Activatable and Glutathione‐Responsive Triptolide Nano‐Prodrug for the Eradication of Pancreatic Cancer
by: Binglin Sui, et al.
Published: (2021-11-01)

An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization
by: Zhang C, et al.
Published: (2022-10-01)

Inhibitory effect of polysulfated heparin endostatin onalkali burn induced corneal neovascularization in rabbits
by: Zhao-Na Li, et al.
Published: (2015-04-01)

Preparation and in vitro and in vivo evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization
by: Rui Zhang, et al.
Published: (2022-12-01)

Dynamic crosslinked polymeric nano-prodrugs for highly selective synergistic chemotherapy
by: Shi Wang, et al.
Published: (2022-11-01)

Enhancing the Inhibition of Corneal Neovascularization Efficacy by Self-Assembled into Supramolecular Hydrogel of Anti-Angiogenic Peptide
by: Pu G, et al.
Published: (2024-07-01)

Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization
by: Halil Ibrahim Onder, et al.
Published: (2014-04-01)

The long-term effect of tacrolimus on alkali burn-induced corneal neovascularization and inflammation surpasses that of anti-vascular endothelial growth factor
by: Chen L, et al.
Published: (2018-09-01)